Skip to main content
Top
Published in: Calcified Tissue International 4/2005

01-04-2005

Increased Incidence of Vertebral Fracture in Older Female Hemodialyzed Patients with Type 2 Diabetes Mellitus

Authors: M. Inaba, S. Okuno, Y. Kumeda, T. Yamakawa, E. Ishimura, Y. Nishizawa

Published in: Calcified Tissue International | Issue 4/2005

Login to get access

Abstract

Bone disease in hemodialysis (HD) patients with type 2 diabetes mellitus (DM) is characterized by low bone turnover (Inaba M, et al. Am J Kidney Dis 2002; 39:1261-1269), although their bone quality is yet to be determined. The present study was designed to examine whether the prevalence of vertebral fracture in female HD patients with type 2 DM, age 65 years and older, might be increased, and the relation of this fracture to bone mineral density (BMD) determined by dual X-ray absorptiometry (DXA), since few data are available on the effect of DM on bone strength at lumbar spine. The prevalence of vertebral fracture in type 2 DM HD patients was 32.3%, which was greater than that of non-DM HD patients (13.3%) when adjusted for age and HD duration. Logistic regression analysis elucidated the presence of DM and age as independent risk factors for an increased prevalence of vertebral fracture in HD patients. In non-DM HD patients, those with vertebral fracture showed age significantly higher and BMD in either lumbar spine or distal one third of radius significantly lower than the respective value in those without fracture. However, in DM HD patients, neither BMD in lumbar spine nor distal one third of radius was significantly lower in those with vertebral fracture than in those without. Furthermore, age did not differ significantly between DM HD patients with and without fracture. In conclusion, female type 2 DM HD patients, age 65 years and older, showed significantly higher incidence of vertebral fracture than non-DM HD patients. Although age and low BMD emerged as independent risk factors for vertebral fracture in non-DM HD patients, those factors failed to be a risk factor in DM HD patients, suggesting that BMD determined by DXA might not be reliable in assessing bone strength in DM HD patients.
Literature
1.
go back to reference Inaba, M, Ishimura, E (2002) “Secondary osteoporosis” In: Moril, H, Nishizawa, Y, Masry, SG, (editors), Calcium in Internal Medicine, Springer-Verlag, London, pp 347–360 Inaba, M, Ishimura, E (2002) “Secondary osteoporosis” In: Moril, H, Nishizawa, Y, Masry, SG, (editors), Calcium in Internal Medicine, Springer-Verlag, London, pp 347–360
2.
go back to reference Rico, H, Hernandez, ER, Cabranes, JA, Gomez-Castresana, F 1989Suggestion of a deficient osteoblastic function in diabetes mellitus. The possible cause of osteopenia in diabeticsCalcif Tissue Int457173CrossRef Rico, H, Hernandez, ER, Cabranes, JA, Gomez-Castresana, F 1989Suggestion of a deficient osteoblastic function in diabetes mellitus. The possible cause of osteopenia in diabeticsCalcif Tissue Int457173CrossRef
3.
go back to reference Bouillon, R, Bex, M, Herck, EV, Laureys, J, Dooms, L, Lesaffre, E, Ravussin, 1995Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitusJ Clin Endocrinol Metab8011941202PubMed Bouillon, R, Bex, M, Herck, EV, Laureys, J, Dooms, L, Lesaffre, E, Ravussin,  1995Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitusJ Clin Endocrinol Metab8011941202PubMed
4.
go back to reference Krakauer, JC, McKenna, MJ, Buderer, NF, Rao, DS, Whitehouse, FW, Parfitt, AM 1995Bone loss and bone turnover in diabetesDiabetes44775782CrossRef Krakauer, JC, McKenna, MJ, Buderer, NF, Rao, DS, Whitehouse, FW, Parfitt, AM 1995Bone loss and bone turnover in diabetesDiabetes44775782CrossRef
5.
go back to reference Inaba, M, Nagasue, K, Okuno, S, Ueda, M, Kumeda, Y, Imanishi, Y, Shoji, T, Ishimura, E, Ohta, T, Nakatani, T, Kim, M, Nishizawa, Y 2002Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitusAm J Kidney Dis3912611269CrossRef Inaba, M, Nagasue, K, Okuno, S, Ueda, M, Kumeda, Y, Imanishi, Y, Shoji, T, Ishimura, E, Ohta, T, Nakatani, T, Kim, M, Nishizawa, Y 2002Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitusAm J Kidney Dis3912611269CrossRef
6.
go back to reference Inaba, M, Okuno, S, Nagasue, K, Otoshi, T, Kurioka, Y, Maekawa, K, Kumeda, Y, Imanishi, Y, Ishimura, E, Ohta, T, Morii, H, Kim, M, Nishizawa, Y 2001Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patientsAm J Kidney Dis38S139142CrossRef Inaba, M, Okuno, S, Nagasue, K, Otoshi, T, Kurioka, Y, Maekawa, K, Kumeda, Y, Imanishi, Y, Ishimura, E, Ohta, T, Morii, H, Kim, M, Nishizawa, Y 2001Impaired secretion of parathyroid hormone is coherent to diabetic hemodialyzed patientsAm J Kidney Dis38S139142CrossRef
7.
go back to reference Inaba, M, Nishizawa, Y, Mita, K, Kumeda, Y, Emoto, M, Kawagishi, T, Ishimura, E, Nakatsuka, K, Shioi, A, Morii, H 1999Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetesOsteoporos Int9525531CrossRef Inaba, M, Nishizawa, Y, Mita, K, Kumeda, Y, Emoto, M, Kawagishi, T, Ishimura, E, Nakatsuka, K, Shioi, A, Morii, H 1999Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetesOsteoporos Int9525531CrossRef
8.
go back to reference Kawagishi, T, Morii, H, Nakatsuka, K, Sasao, K, Kawasaki, K, Miki, T, Nishizawa, Y 1991Parathyroid hormone secretion in diabetes mellitusContrib Nephrol9021722CrossRef Kawagishi, T, Morii, H, Nakatsuka, K, Sasao, K, Kawasaki, K, Miki, T, Nishizawa, Y 1991Parathyroid hormone secretion in diabetes mellitusContrib Nephrol9021722CrossRef
9.
go back to reference Schwartz, AV, Sellmeyer, DE, Ensrud, KE, Cauley, JA, Tabor, HK, Schreiner, PJ, Jamal, SA, Black, DM, Cummings, SR 2001Older women with diabetes have an increased risk of fracture: a prospective studyJ Clin Endocrinol Metab863238CrossRef Schwartz, AV, Sellmeyer, DE, Ensrud, KE, Cauley, JA, Tabor, HK, Schreiner, PJ, Jamal, SA, Black, DM, Cummings, SR 2001Older women with diabetes have an increased risk of fracture: a prospective studyJ Clin Endocrinol Metab863238CrossRef
10.
go back to reference Atsumi, K, Kushida, K, Yamazaki, K, Shimizu, S, Ohmura, A, Inoue, T 1999Risk factors for vertebral fractures in renal osteodystrophyAm J Kidney Dis33287293CrossRef Atsumi, K, Kushida, K, Yamazaki, K, Shimizu, S, Ohmura, A, Inoue, T 1999Risk factors for vertebral fractures in renal osteodystrophyAm J Kidney Dis33287293CrossRef
11.
go back to reference Coco, M, Rush, H 2000Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormoneAm J Kidney Dis36:11151121CrossRef Coco, M, Rush, H 2000Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormoneAm J Kidney Dis36:11151121CrossRef
12.
go back to reference Piraino, B, Chen, T, Cooperstein, L, Segre, G, Puschett, J 1988Fractures and vertebral bone mineral density in patients with renal osteodystrophyClin Nephrol305762PubMed Piraino, B, Chen, T, Cooperstein, L, Segre, G, Puschett, J 1988Fractures and vertebral bone mineral density in patients with renal osteodystrophyClin Nephrol305762PubMed
13.
go back to reference Nelson, DA, Jacober, SJ 2001Editorial: Why do older women with diabetes have an increased fracture risk?J Clin Endocrinol Metab862931CrossRef Nelson, DA, Jacober, SJ 2001Editorial: Why do older women with diabetes have an increased fracture risk?J Clin Endocrinol Metab862931CrossRef
14.
go back to reference WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva, WHO WHO Study Group (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 843. Geneva, WHO
15.
go back to reference Schaffler, MR 2003Role of bone turnover in microdamageOsteoporos Int14S73S80CrossRef Schaffler, MR 2003Role of bone turnover in microdamageOsteoporos Int14S73S80CrossRef
16.
go back to reference American Diabetes Association1998Mellitus TECotDacoD. Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care21S5S22 American Diabetes Association1998Mellitus TECotDacoD. Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care21S5S22
17.
go back to reference Kumeda, Y, Inaba, M, Tahara, H, Kurioka, Y, Ishikawa, T, Morii, H, Nishizawa, Y 2000Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidismJ Clin Endocrinol Metab8541574161PubMed Kumeda, Y, Inaba, M, Tahara, H, Kurioka, Y, Ishikawa, T, Morii, H, Nishizawa, Y 2000Persistent increase in bone turnover in Graves’ patients with subclinical hyperthyroidismJ Clin Endocrinol Metab8541574161PubMed
18.
go back to reference Ishimura, E, Okuno, S, Kim, M, Yamamoto, T, Izumotani, T, Otoshi, T, Shoji, T, Inaba, M, Nishizawa, Y 2001Increasing body fat mass in the first tear of hemodialysisJ Am Soc Nephrol1219211926PubMed Ishimura, E, Okuno, S, Kim, M, Yamamoto, T, Izumotani, T, Otoshi, T, Shoji, T, Inaba, M, Nishizawa, Y 2001Increasing body fat mass in the first tear of hemodialysisJ Am Soc Nephrol1219211926PubMed
19.
go back to reference Ueda, M, Inaba, M, Okuno, S, Nagasue, K, Kitatani, K, Ishimura, E, Shimizu, M, Miki, T, Kim, M, Nishizawa, Y 2002Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patientsAm J Kidney Dis40802809CrossRef Ueda, M, Inaba, M, Okuno, S, Nagasue, K, Kitatani, K, Ishimura, E, Shimizu, M, Miki, T, Kim, M, Nishizawa, Y 2002Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patientsAm J Kidney Dis40802809CrossRef
20.
go back to reference Cummings, SR, Black, DM, Nevitt, MC, Browner, W, Cauley, J, Ensrud, K, Genant, HK, Palermo, L, Scott, J, Vogt, TM 1993Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research GroupLancet.3417275CrossRef Cummings, SR, Black, DM, Nevitt, MC, Browner, W, Cauley, J, Ensrud, K, Genant, HK, Palermo, L, Scott, J, Vogt, TM 1993Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research GroupLancet.3417275CrossRef
21.
go back to reference Inaba, M, Terada, M, Koyama, H, Yoshida, O, Ishimura, E, Kawagishi, T, Okuno, Y, Nishizawa, Y, Otani, S, Morii, H 1995Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cellsJ Bone Miner Res1010501060CrossRef Inaba, M, Terada, M, Koyama, H, Yoshida, O, Ishimura, E, Kawagishi, T, Okuno, Y, Nishizawa, Y, Otani, S, Morii, H 1995Influence of high glucose on 1,25-dihydroxyvitamin D3-induced effect on human osteoblast-like MG-63 cellsJ Bone Miner Res1010501060CrossRef
22.
go back to reference Terada, M, Inaba, M, Yano, Y, Hasuma, T, Nishizawa, Y, Morii, H, Otani, S 1998Growth-inhibitory effect of a high glucose concentration on osteoblast-like cellsBone221723CrossRef Terada, M, Inaba, M, Yano, Y, Hasuma, T, Nishizawa, Y, Morii, H, Otani, S 1998Growth-inhibitory effect of a high glucose concentration on osteoblast-like cellsBone221723CrossRef
23.
go back to reference Inaba, M, Terada, M, Nishizawa, Y, Shioi, A, Ishimura, E, Otani, S, Morii, H 1999Protective effect of aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of polyol pathway in bone metabolismMetabolism48904909CrossRef Inaba, M, Terada, M, Nishizawa, Y, Shioi, A, Ishimura, E, Otani, S, Morii, H 1999Protective effect of aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of polyol pathway in bone metabolismMetabolism48904909CrossRef
24.
go back to reference Inaba, M, Nishizawa, Y, Shioi, A, Morii, H 1997Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathwayOsteoporos Int 7.S209S212CrossRef Inaba, M, Nishizawa, Y, Shioi, A, Morii, H 1997Importance of sustained high glucose condition in the development of diabetic osteopenia: possible involvement of the polyol pathwayOsteoporos Int 7.S209S212CrossRef
25.
go back to reference Vogt, MT, Cauley, JA, Kuller, LH, Nevitt, MC 1977Bone mineral density and blood flow to the lower extremities: The Study of Osteoporotic FracturesJ Bone Miner Res12283289CrossRef Vogt, MT, Cauley, JA, Kuller, LH, Nevitt, MC 1977Bone mineral density and blood flow to the lower extremities: The Study of Osteoporotic FracturesJ Bone Miner Res12283289CrossRef
26.
go back to reference Piepkorn, B, Kann, P, Forst, T, Andreas, J, Pfutzner, A, Beyer, J 1997Bone mineral density and bone metabolism in diabetes mellitusHorm Metab Res29584591CrossRef Piepkorn, B, Kann, P, Forst, T, Andreas, J, Pfutzner, A, Beyer, J 1997Bone mineral density and bone metabolism in diabetes mellitusHorm Metab Res29584591CrossRef
27.
go back to reference Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2001Diabetes and risk of fractureDiabetes Care2411981203CrossRef Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2001Diabetes and risk of fractureDiabetes Care2411981203CrossRef
28.
go back to reference Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2000Diabetes and risk of fracture: the Blue Mountains Eye StudyDiabetes Care2411982003CrossRef Ivers, RQ, Cumming, RG, Mitchell, P, Peduto, AJ 2000Diabetes and risk of fracture: the Blue Mountains Eye StudyDiabetes Care2411982003CrossRef
29.
go back to reference Nicodemus, K, Folsom, AR 2001Type 1 and type 2 diabetes and incident hip fracture in postmenopausal womenDiabetes Care2411921197CrossRef Nicodemus, K, Folsom, AR 2001Type 1 and type 2 diabetes and incident hip fracture in postmenopausal womenDiabetes Care2411921197CrossRef
30.
go back to reference Chau, DL, Edelman, SV 2002Osteoporosis and DiabetesClin Diabetes20153157CrossRef Chau, DL, Edelman, SV 2002Osteoporosis and DiabetesClin Diabetes20153157CrossRef
Metadata
Title
Increased Incidence of Vertebral Fracture in Older Female Hemodialyzed Patients with Type 2 Diabetes Mellitus
Authors
M. Inaba
S. Okuno
Y. Kumeda
T. Yamakawa
E. Ishimura
Y. Nishizawa
Publication date
01-04-2005
Publisher
Springer New York
Published in
Calcified Tissue International / Issue 4/2005
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0094-0

Other articles of this Issue 4/2005

Calcified Tissue International 4/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine